Not finding it? Sign in to also search OpenAlex live.
-
Impact of the addition of antithymocyte globulin to post‐transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post‐transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation2025 British Journal of Haematology article Medicine Hematopoietic Stem Cell Transplantation Open access
Antoine Capes, Jarl Mooyaart, Didier Blaise, Stéfania Bramanti, Mi Kwon, Mohamad Mohty, +13 more
5citations -
Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +27 more
15citations -
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Giovanni O. Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +24 more
12citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
Martin G. McCabe, Laura Kirton, Maria Khan, Nicola Fenwick, Sandra J. Strauss, Claudia María Valverde, +13 more
46citations -
Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +24 more
15citations -
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation2021 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
Firoozeh Sahebi, Dirk‐Jan Eikema, Linda Köster, Nicolaus Kröger, Ellen Meijer, Jaap A. van Doesum, +20 more
10citations -
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study2022 American Journal of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Vaishali Sanchorawala, Giovanni O. Palladini, Monique C. Minnema, Arnaud Jaccard, Hans Chulhee Lee, Simon DJ Gibbs, +28 more
10citations -
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)2023 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
Guillermo Ortí, Luuk A. Gras, Linda Köster, Alexander Kulagin, Jenny Byrne, Jane F. Apperley, +20 more
9citations -
Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Vaishali Sanchorawala, Giovanni O. Palladini, Monique C. Minnema, Arnaud Jaccard, Hans Chulhee Lee, Simon DJ Gibbs, +28 more
7citations -
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation2024 American Journal of Hematology article Medicine Hematopoietic Stem Cell Transplantation Open access
Frédéric Baron, Myriam Labopin, Jurjen Versluis, Jan Vydra, Peter A. von dem Borne, Emma Nicholson, +12 more
3citations -
Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia
Peter A. von dem Borne, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriëtte Levenga, +9 more
1citations -
Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT
Firoozeh Sahebi, Dirk‐Jan Eikema, Linda Köster, Nicolaus Martin Kröger, Ellen Meijer, Goda Choi, +19 more
1citations -
Decreased Chronic GvHD With Post‐Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT2026 American Journal of Hematology article Medicine Hematopoietic Stem Cell Transplantation Open access
Yves Chalandon, Edouard F. Bonneville, Diderik-Jan Eikema, Liesbeth C. de Wreede, Linda Köster, Joe Tuffnell, +24 more
1citations -
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Gesine Bug, Myriam Labopin, Alexander Kulagin, Didier Blaise, Anna Maria Raiola, Jan Vydra, +13 more
0citations -
Decreased Chronic GvHD with Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelofibrosis Allografted with Unrelated Donor: A Study from the Chronic Malignancies Working Party of the EBMT
Yves Chalandon, Edouard F. Bonneville, Liesbeth C. de Wreede, Linda Köster, Joe Tuffnell, Jakob Robert Passweg, +23 more
0citations -
Comparative Study of Unrelated and Haploidentical Donor Hematopoietic Cell Transplant for Chronic Myeloid Leukemia with Post Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis: A Study from the Chronic Malignancies Working Party of EBMT
Guillermo Ortí, Luuk A. Gras, Nienke Zinger, Alexander Kulagin, Jenny Byrne, Jane F. Apperley, +18 more
0citations -
Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
Peter A. von dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Daniëlle van Lammeren, +10 more
0citations -
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms2026 UTUPub (University of Turku) article Medicine Hematopoietic Stem Cell Transplantation Open access
Yves Chalandon, Diderik-Jan Eikema, Ivan Moiseev, Fabio Ciceri, Linda Köster, Jan Vydra, +17 more
0citations -
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide2025 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Alexandros Spyridonidis, Myriam Labopin, Bipin N. Savani, Alexander Kulagin, Didier Blaise, Annoek E. C. Broers, +15 more
4citations